# Hereditary Hemorrhagic Telangiectasia (HHT) Center

Source: https://welltoldgrants.com/grants/hrsa-22-145-hereditary-hemorrhagic-telangiectasia-hht-center/  
Official notice: https://www.grants.gov/search-results-detail/338789

> Health Resources and Services Administration offered grants of up to $2.0 million to nonprofits, state and local governments, tribes, small businesses and businesses. It expected to make one award worth $2.0 million in total. Applications closed on May 17, 2022.

| Field | Value |
|---|---|
| Opportunity number | HRSA-22-145 |
| Agency | Health Resources and Services Administration |
| Status | Forecast |
| Deadline | May 17, 2022 |
| Award ceiling | $2.0 million |
| Award floor | not stated |
| Expected awards | 1 |
| Total funding | $2.0 million |
| Cost sharing | not required |
| Assistance Listings | 93.110 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Any domestic public or private entity, including an Indian tribe or tribal organization (as those terms are defined at 25 U.S.C. 5304 (formerly cited as 25 U.S.C. 450b)) is eligible to apply. See 42 CFR § 51a.3(a)). Domestic faith-based and community-based organizations are eligible to apply.

## What the grant funds

The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2022 Hereditary Hemorrhagic Telangiectasia (HHT) Center. The purpose of the program is to reduce morbidity and mortality associated with hereditary hemorrhagic telangiectasia by funding a national center to: 1) expand access to and coordination of care for HHT patients; and 2) develop a de-identified, aggregate data collection registry to better understand this rare disease and treatment outcomes.

## Questions people ask

### Is HRSA-22-145 still open?

No. It closed on May 17, 2022. A newer notice is open: HRSA-27-072, closes January 8, 2027 (62 days left).

### Who can apply for Hereditary Hemorrhagic Telangiectasia (HHT) Center?

Health Resources and Services Administration accepted applications from nonprofits, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Hereditary Hemorrhagic Telangiectasia (HHT) Center?

Closed May 17, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $2.0 million each. About $2.0 million in total for one award.

### Who has won Special Projects of Regional and National Significance grants before?

The largest recipients over five fiscal years were Zero to Three National Center for Infants, Toddlers & Families, University Hospitals Cleveland Medical Center, Children's National Medical Center. The program made 842 awards worth $1.4 billion in that time.